SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is surging as a nostalgic yet serious cultural movement, leveraging its 2011 origin as the internet's original Bitcoin parody to capture investor attention. The community is actively highlighting its deep historical roots, recent high-profile whale endorsements, and its transition onto modern blockchain infrastructure as key factors driving its momentum.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as the community leans into its established two-year Solana history, using persistent meme-driven engagement and organic social promotion to rally holders. Investors are actively discussing the token's presence on the Jupiter strict list and its role within the broader meme coin meta, with discussions centered on whale accumulation and long-term community dedication.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is seeing increased community chatter surrounding its role as a key liquidity hub on the Base ecosystem, with investors closely watching potential catalyst events and revenue growth. Community sentiment remains mixed, as some participants express frustration with current price action while others double down on accumulation strategies in anticipation of long-term utility gains.

Dumb SEND IT

Dumb SEND IT ($DSIT) is gaining traction as a high-volatility meme coin on the Solana network, with the community actively celebrating its early growth, developer accessibility, and airdrop events. Traders are focused on pushing the token past key market cap milestones while encouraging engagement through aggressive social media activity and strategic buying during dips.

Orca is the most user-friendly DEX on Solana.  Orca is one of the first general-purpose AMMs launched on Solana. Users can swap assets, provide liquidity, and earn yield through an easy-to-use interface. Projects can use Orca as a money-lego to easily integrate swapping, farming, or on-chain data into their dApp.  Orca strives to provide easy and effective financial tools for everyone, bringing DeFi to the masses.

Orca

ORCA is experiencing a massive short squeeze following a significant uptick in trading volume and public attention related to its role in the Solana ecosystem. Community members are actively debating the token's explosive price action, with some focused on the potential for continued momentum while others caution against the volatility of this pump.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as investors react to the FDA lifting the clinical hold on its Phase 3 MAGNITUDE trial, signaling a key de-risking event for the company's heart disease gene therapy pipeline. The community is actively discussing the stock's significant short interest and the potential for a recovery toward previous highs as traders weigh clinical progress against broader macroeconomic volatility.

TRUMP is a politics-themed digital coin built on the Solana blockchain that uses the brand of Donald Trump to foster a community-driven ecosystem. As a community-focused asset, it is designed to bridge political support with web ownership, operating within the PolitiFi sector to blend political movements with decentralized finance tools. The project's main value proposition lies in its official ties to Donald Trump’s media and business brands, which allows it to provide unique physical utility such as invitations to gala dinners and meetings at Mar-a-Lago.  The token serves as the primary currency for the officially licensed Trump Billionaires Club mobile and web game, where it is used for in-game purchases and unlocking features. By leveraging the Solana blockchain, the project ensures that these in-game actions and token transfers remain fast and cost-effective. The ecosystem remains stable through a programmatic release schedule that introduces new tokens slowly to prevent supply shocks, alongside the use of specialized market makers to maintain consistent liquidity for traders.  Holders can also participate in liquidity sharing by providing their tokens to automated systems to facilitate trading for others, often earning rewards or prizes in return. Beyond digital utility, holding a specific amount of the token is a requirement for attending exclusive real-world events, including VIP parties at Mar-a-Lago. The project is managed by the Trump Meme Team and is linked with Trump Media, with an investor base that includes a wide range of retail buyers and large holders who utilize secure custody services for their assets.

Trump For President

The TRUMP meme coin is facing severe downward pressure and community backlash, with investors reacting to allegations of a "pump and dump" scheme and frustration over the coin's utility following recent high-profile events. The conversation is dominated by intense political polarization, with critics citing the coin as part of a broader pattern of financial exploitation while supporters continue to debate its role as a speculative asset.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is experiencing heightened investor attention driven by sustained trading volume, fueling persistent community speculation regarding a potential buyout or strategic partnership. While investors are closely monitoring clinical developments and the company's financial runway, the market remains reactive to these recurring M&A rumors despite a lack of formal announcements.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as holders actively accumulate during a consolidation phase, citing the project's unique "phygital" strategy and retail presence as key pillars for long-term growth. While some investors debate the risks of meme coin volatility, the community is heavily focused on potential breakout triggers and the project's ongoing brand expansion efforts.

Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Cameco is currently trending as investors focus on the company's central role in the nuclear energy sector, bolstered by significant federal investments in reactor buildouts and sustained long-term demand for uranium as a baseload power source for AI infrastructure. The community is actively discussing Cameco's strong institutional support and its strategic positioning within the nuclear fuel cycle while weighing the stock's recent price appreciation against long-term growth prospects.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The year-over-year increase in revenue reflects strong performance across all of the&nbsp;company’s business segments.</li><li>Argan reported net income of $49.2 million, or $3.47 per diluted share, compared to $31.4 million, or $2.22 per diluted share in the year-ago quarter.</li><li>The profit also sailed past Wall Street projections of $1.98 per share, as per data from Stocktwits.&nbsp;</li></ul>Argan&nbsp;Inc. (AGX) stock rallied almost 9% during extended hours of trading on Thursday after it reported upbeat fourth-quarter (Q4) earnings, helped by strong segment performance.&nbsp;Argan’s consolidated revenues for the quarter ended Jan. 31, 2026, were $262.1 million, an increase of $29.6 million, or 12.7%, from consolidated revenues of $232.5 million reported for the comparable prior-year quarter. Wall Street projected revenue of $255.3 million, as per Stocktwits data.&nbsp;The year-over-year increase reflects higher revenues across all of the&nbsp;company’s business segments. In the power segment, revenues increased as recently awarded contracts progressed through the early stages of construction, generating revenues that were not present in the prior-year period,&nbsp;the company said.“Our record fourth quarter performance capped a year of strong execution throughout fiscal 2026, driving record top and bottom-line performance for the full year,” said David Watson, President and&nbsp;CEO of Argan.&nbsp;“During the year, we added $2.5 billion in new contract value, increasing our consolidated project backlog to more than $2.9 billion at year-end, reflecting substantial growth across the entire Argan platform,” Watson added.&nbsp;<h2 class="st-heading-2">Profit Figures</h2>Argan reported net income of $49.2 million, or $3.47 per diluted share, compared to $31.4 million, or $2.22 per diluted share in the year-ago quarter. The profit also sailed past Wall Street projections of $1.98 per share, as per data from Stocktwits.Argan’s consolidated gross profit was $65.6 million, or 25.0% of consolidated revenues versus $47.6 million, or 20.5% of consolidated revenues in the year-ago quarter.&nbsp;The increase from the comparable prior-year quarter is primarily due to improved gross profit margins for the power segment, reflecting strong project execution, including the early achievement of substantial completion at the Trumbull Energy Center, the company said.&nbsp;<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment around AGX stock trended in ‘bullish’ territory amid ‘extremely high’ message volume.&nbsp;Shares in the company have risen almost 30% so far this year.&nbsp;&nbsp;&nbsp;

Shares in Argan have risen almost 30% so far in 2026.

Argan Stock Jumps More Than 9% After Hours On Upbeat Q4 Earnings 

Argan’s consolidated revenues for the quarter ended Jan. 31, 2026, were $262.1 million, rising nearly 13% from the year-ago quarter. 

Equity

Argan’s consolidated revenues for the quarter ended Jan. 31, 2026, were $262.1 million, rising nearly 13% from the year-ago quarter. 


<ul class="summary-bullets"><li>The company reported revenues of $27.07 million for the year ended Dec. 31, 2025 compared to $22.62 million for the same period in 2024, an increase in revenues of 19.7% year over year.</li><li>The rise in FY25 revenue was helped by a 105.5% jump in its products revenues.</li><li>Its net loss of $8.25 million for FY25 widened compared to $4.76 million for the same period in 2024.</li></ul>Tecogen (TGEN) stock jumped 6% during extended hours of trading on Tuesday after it reported its full year 2025 results that beat Wall Street expectations.&nbsp;The company reported revenues of $27.07 million for the year&nbsp;ended Dec. 31, 2025, compared to $22.62 million for the same period in 2024, an increase in revenues of 19.7% year over year, helped by a 105.5% jump in its products revenues. Analysts expected revenue of $26.49 million, as per data from Stocktwits.&nbsp;However, its net loss of $8.25 million for FY25 widened compared to $4.76 million for the same period in 2024. The loss increased due to the impairment of goodwill and long-lived assets, increased operating expenses and decreased gross profit from&nbsp;its&nbsp;Services segments,&nbsp;the company said.&nbsp;“Our revenue grew 20% year on year. Although our loss widened and cash burn increased, this was because of critical expenses needed to expand margins in the service business and to develop the data center opportunities including expanding manufacturing capacity, R&amp;D on our data center dual power source chiller and marketing," said Abinand Rangesh, CEO of Tecogen.<h2 class="st-heading-2">Quarter Performance</h2>Revenues for the fourth quarter were $5.32 million compared to $6.08 million for the same period in 2024, a 12.5% decrease due to weakness in its products segment.&nbsp;However, Services revenues in the quarter came at $4.46 million, compared to $4.08 million for the same period in 2024, an increase of 9.3% due to a $0.36 million increase in revenues from existing contracts and a $0.01 million increase in revenues from the acquired Aegis maintenance contracts, the company said.&nbsp;The company reported a loss per share of $0.13 per share in the fourth quarter, compared to $0.05 per share from the year-ago quarter. Analysts on average expected a loss per share of $0.10 according to data from Stocktwits.&nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around TGEN stock trended in ‘neutral’ territory amid ‘high’ message volume.&nbsp;Shares in the company have fallen nearly 44% year to date.&nbsp;

Retail sentiment around TGEN stock trended in ‘neutral’ territory amid ‘high’ message volume. 

Why Is TGEN Stock Rising After Hours?

Tecogen reported full year 2025 results on Tuesday, with revenue beating Wall Street expectations. 

Eastman Kodak’s shares rallied nearly 12% in extended hours of trading on Thursday after it reported strong growth in its fourth-quarter revenue.&nbsp;Kodak reported consolidated revenues of $290 million in the fourth quarter of 2025, compared with $266 million in the year-ago period, an increase of $24 million or 9%. The rise in revenue was driven by strong performance in Advanced Materials &amp; Chemicals (AM&amp;C) and Print segments.&nbsp;“Kodak ended 2025 with a strong fourth quarter, which has created a foundation for growth in 2026,” said Jim Continenza, Kodak’s Executive Chairman and CEO. “We continue to execute the long-term plan we began in 2019, which focuses on de-levering the company while continuing to invest in our infrastructure and new product innovation”.&nbsp;Kodak ended the year with a cash balance of $337 million, an increase of $136 million from December 31, 2024. The increase was primarily due to the net impact of the Kodak Retirement Income Plan (KRIP) termination and reversion of assets to the company of $153 million.The company reported GAAP net loss of $108 million in Q4 2025, compared with net income of $26 million for Q4 2024. The decline in net income was primarily due to the non-recurring impact of the Kodak Retirement Income Plan ("KRIP") termination and excise tax paid on the reversion of assets to the company.<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment around KODK stock trended in ‘bullish’ territory amid ‘extremely high’ message volume.&nbsp;One user on Stocktwits called the share rise ‘better than expected’.<stembedurl>https://stocktwits.com/PharmGal/message/647406000</stembedurl>A bullish user said they are optimistic for Kodak in 2026.&nbsp;<stembedurl>https://stocktwits.com/NikkyBenz13/message/647405165</stembedurl>Another bullish user opined that continued growth in Kodak’s Advanced Materials &amp; Chemicals is especially encouraging and could open doors to new markets.&nbsp;<stembedurl>https://stocktwits.com/Judykay/message/647399877</stembedurl>Shares in the company are down 9.4% so far in 2026.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

In this photo illustration, the Eastman Kodak Company logo is seen displayed on a smartphone screen.

Eastman Kodak Stock Rallies After-Hours As Q4 Revenue Jumps On Strong Segment Performance

Kodak reported consolidated revenues of $290 million in the fourth quarter of 2025, compared with $266 million in the year-ago period, an increase of $24 million or 9%.

<ul class="summary-bullets"><li>In its bid to add more mortgage options to its platform, Opendoor acquired homebuyer.com, a mortgage data platform, in Dec. last year.&nbsp;</li><li>OPEN’s CEO said that the company shipped its latest feature late Thursday.&nbsp;</li><li>The real estate digital platform on Thursday posted revenue for the fourth-quarter (Q4) of $736 million, much above street expectations of $591.75 million, as per data from Fiscal.ai.</li></ul>OpenDoor's (<a href="https://stocktwits.com/symbol/OPEN">OPEN</a>) Chief Executive Officer Kaz Nejatian in an exclusive interview to Stocktwits on Friday hinted that the company's mortgage product is in beta phase as the company pushes to enable itself to issue its own mortgage on homes it sells, helping cut out middlemen.“I left the earnings call and came to the office and started working on our product because we actually shipped a new feature late last night around 11 p.m. So I was up a little late shipping,” Nejatian told Stocktwits’ in an <a href="https://stocktwits.com/symbol/OPEN/event/f9cbb7c3-0777-4d00-8179-249bbbf2628b">interview</a>.&nbsp;In its bid to add more mortgage options to its platform, Opendoor acquired homebuyer.com, a mortgage data platform, in Dec. last year. The deal fits OPEN’s CEO Kaz’s AI-pilled vision of using data to eliminate ‘toilful work’ like manual paperwork.<h2 class="st-heading-2">Critical Of Fed</h2>Nejatian criticized the U.S. Federal Reserve for maintaining the interest rates at the level they are.&nbsp;“I think the Fed is being deeply irresponsible these days with maintaining these interest levels,” he told Stocktwits.&nbsp;“Trueflation, which is a much better measure of inflation than CPI, truflation has been sub 1 % basically the entire year. The Fed is asking people to believe that Bureau of Labor Statistics’ (BLS) data is a more reliable source for inflation and what's happening to the economy than truflation. And no one believes that. There's no one who invests their own money who would look at BLS data,” he added.&nbsp;The Federal Reserve kept the benchmark interest unchanged at 3.5%-3.75% in its January meeting. The latest Federal Open Market Committee’s (FOMC) minutes released by the Fed earlier this week revealed that the central bank might hike the interest rates if inflation does not come down to its targeted range.&nbsp;“I think it is highly irresponsible to have artificially elevated interest rates at this time. And I think they need to do something because this is just like, it's very odd,” Nejatian further added.&nbsp;<h2 class="st-heading-2">Q4 Earnings</h2>The real estate digital platform posted revenue for the fourth-quarter (Q4) of $736 million, much above street expectations of $591.75 million, as per data from Fiscal.ai. Meanwhile, the company’s loss per share came in at $1.26, trailing market expectations of a loss per share of $0.11.Opendoor said that it expects Q1 revenue to decrease approximately 10% quarter-over-quarter.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around OPEN trended in ‘extremely bullish’ territory amid ‘extremely high’ message volume.&nbsp;Shares in the company have risen 221% over the past year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

Kaz Nejatian, CEO, Opendoor, speaks onstage during "At the Builder's Table: Building Successful Businesses" panel in Atlanta, Georgia.

Exclusive: Opendoor CEO Reveals Company’s Own Mortgage Product Is In Beta Phase, Criticizes Fed On Interest Rates

OPEN’s CEO Kaz Nejatian said that truflation is a much better measure of inflation and no one who invests their own money looks at BLS data. 

<ul class="summary-bullets"><li>Palantir’s software will also run in Rackspace’s Private Cloud and U.K. Sovereign data centers.</li><li>Rackspace plans to increase the number of engineers trained on Palantir’s technologies to more than 250 over the next year from 30 currently.</li><li>The companies expect the partnership to significantly shorten AI deployment timelines.</li></ul>Shares of Rackspace Technology (RXT) extended their gains after the opening bell on Wednesday, building on a more than twofold surge in pre-market trading, after the company announced a partnership with Palantir Technologies (PLTR) to help enterprises rapidly deploy Palantir’s Foundry and Artificial Intelligence Platform.At the time of writing, <a href="https://stocktwits.com/symbol/RXT">RXT shares</a> were up 275%, while <a href="https://stocktwits.com/symbol/PLTR">PLTR stock</a> climbed 4.7%.<h2 class="st-heading-2">Rackspace To Deploy Palantir Software In UK</h2>As part of the agreement, Palantir’s software will also run in Rackspace’s Private Cloud and U.K. Sovereign data centers. Rackspace currently has 30 engineers trained on Palantir’s technologies to assist with data migration and complex deployments, and plans to expand that number to more than 250 over the next year. The companies expect the partnership to significantly shorten AI deployment timelines.“Palantir’s platform, combined with Rackspace's governed cloud operations and our shared forward-deployed engineering approach, enables customers to accelerate time to value and drive competitive business impact with governance and security. This is especially important in regulated industries,” said Gajen Kandiah, CEO of Rackspace Technology.&nbsp;<h2 class="st-heading-2">Rackspace’s VMware Sovereign Cloud Partner Status</h2>Last month, Rackspace Technology announced that its U.K. Sovereign Services cloud platform earned VMware Sovereign Cloud Partner Status, confirming that it meets data sovereignty standards. The company said the designation validates its ability to comply with national privacy and security regulations.The company’s Sovereign Services platform offers a fully managed private cloud built on VMware technologies and operated from U.K.-based data centers. The platform serves public-sector agencies, financial services, and healthcare services.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits changed to ‘extremely bullish’ from ‘bullish’ a day earlier, amid ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/RXT_jpg_0a659176f3.webp" alt="RXT.jpg">One user commented saying it’s the “right partnership” and a “buyout target.”<stembedurl>https://stocktwits.com/stockjock2424/message/645242737</stembedurl>Another user expects the stock to climb to $1.90 if it breaks past the $1.70 resistance. RXT stock is currently trading at around $1.5.<stembedurl>https://stocktwits.com/tmpalider/message/645242734</stembedurl>The stock has gained around 50% so far in 2026.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

RXT Stock Soared 275% Today – What’s The Connection With Palantir?

The company announced it would help businesses rapidly deploy Palantir’s Foundry and Artificial Intelligence Platform.

<ul class="summary-bullets"><li>The company also said it expects $10 million to $20 million in adjusted EBITDA in FY2027.&nbsp;</li><li>The company said for the third quarter its revenue was $16.3 million versus $40.7 million in the prior-year quarter, a 60% decrease.</li><li>Direct Operating Margin was 69%, compared to 48% in the prior year quarter, reflecting the company's continued focus on cost management.&nbsp;</li></ul>Shares of Cineverse (<a href="https://stocktwits.com/symbol/CNVS">CNVS</a>) jumped on Tuesday after it posted higher-than-expected outlook for its FY 2027 revenue.&nbsp;The company said it expects $115 million to $120 million in revenue for fiscal year 2027, that commences from April 1, 2026. Analysts on average were expecting the revenue of $85.23 million, as per data from fiscal.ai.&nbsp;The company also said it expects $10 million to $20 million in adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in FY2027.&nbsp;"Already, we have seen extremely positive results from the Giant acquisition over the last 6 weeks, and IndiCue's month-over-month financial performance prior to acquisition was scaling up very rapidly. Therefore, we feel very confident in the financial guidance we are issuing for Fiscal Year 2027, which begins April 1, 2026, of $115 to $120 million in Revenue and $10 to $20 million in Adjusted EBITDA," said Chris McGurk, Cineverse Chairman and CEO.&nbsp;<h2 class="st-heading-2">Q4 Snapshot</h2>The company said for the third quarter its revenue was $16.3 million versus $40.7 million in the prior-year quarter, a 60% decrease, due to approximately $22.8 million of theatrical revenue from Terrifier 3 in the prior year fiscal quarter. The revenue was also below analysts’ estimates of $20 million, as per data from fiscal.ai.&nbsp;Direct Operating Margin was 69%, compared to 48% in the prior year quarter, reflecting the company's continued focus on cost management.&nbsp;The company said its total streaming viewers increased approximately 10% year-over-year in Q3 FY26 to 149 million.&nbsp;The company’s net loss attributable to common stockholders was $1.0 million, or $0.05 per basic and diluted share, compared to a net profit of $7.0 million, or $0.34 per share, in the prior-year quarter. Analysts expected a loss of $0.03 per share.&nbsp;"Our financial objective during this quarter was to focus on improving operating results in our base business in anticipation of closing the transformative Giant and IndiCue acquisitions. We are very pleased that these efforts paid off, with significant increases in both Direct Operating Margins and Adjusted EBITDA,” said McGurk.&nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around CNVS trended in ‘bullish’ territory amid ‘high’ message volume.&nbsp;Shares in the company have fallen 36.4% over the past year.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/new-york-times-sahres-are-rallying-what-is-the-connection-with-berkshire-hathaway/cZRWySkR4H3">NYT Stock Is Rallying After-Hours – What Is The Berkshire Hathaway Connection?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Shares of Cineverse jumped on Tuesday after it posted higher-than-expected outlook for its FY 2027 revenue. 

Why Is Cineverse Stock Rising Despite Missing Q3 Revenue and Earnings Estimates?

The company said it expects $115 million to $120 million in revenue for fiscal year 2027, however analysts on average were expecting the revenue of $85.23 million, as per data from fiscal.ai. 

<ul class="summary-bullets"><li>The company posted a net income available to common shareholders of $89.1 million, compared to a net loss of $286.4 million in the third quarter 2024.</li><li>Its revenue also jumped to $277.9 million, compared to $175.4 million in the third quarter 2024.</li><li>The company said strong financial performance in the third quarter was led by the Capital Markets segment.&nbsp;</li></ul>BRC Group Holdings, formerly known as B.Riley Financial, rallied in after-market hours on Wednesday after it announced its delayed quarterly results.&nbsp;The company filed financial reports for three quarters within 120 days, achieving NASDAQ compliance ahead of the deadline, it said in a regulatory filing.&nbsp;<h2 class="st-heading-2">Q3 Results</h2>The company posted a net income available to common shareholders of $89.1 million, compared to a net loss of $286.4 million in the third quarter 2024. The company said basic and diluted earnings per common share were $2.91 compared to a loss per share of $9.39 in the third quarter 2024.Its revenue also jumped to $277.9 million, compared to $175.4 million in the third quarter 2024. The company said strong financial performance in the third quarter was led by the Capital Markets segment with $65.4 million in services and fee revenues, the highest quarterly total since the fourth quarter of 2023.“We are pleased with the third quarter financial results. B. Riley Securities had a very strong quarter across investment banking, advisory, and research and trading with equity and debt capital raises totaling approximately $10.5 billion while delivering product innovation,” Bryant Riley, Chairman and Co-Chief Executive Officer of BRC, said.&nbsp;“Our Communications segment produced strong cash flow, consistent with previous quarters. B. Riley Wealth enhanced products and services for clients, while reducing costs and integrating its back office,” he added.&nbsp;<h2 class="st-heading-2">B.Riley Woes</h2>BRC’s struggles to file timely earnings reports started after a turbulent period in 2024 when it grappled with soured investments, flaws in financial reporting and a U.S. civil investigation.Franchise Group was a key investor of BRC and its bankruptcy in late 2024 left B. Riley burdened with write-offs of hundreds of millions of dollars and it was unable to file its annual and quarterly reports with US regulators on a timely basis. &nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around RILY trended in ‘extremely bullish’ territory amid ‘high’ message volume.&nbsp;One user predicted the stock could hit $15 on Thursday.<a href="https://stocktwits.com/SelectiveTrader/message/641848445">https://stocktwits.com/SelectiveTrader/message/641848445</a>Shares of RILY have jumped 53% over the past year.&nbsp; &nbsp;

Chairman, B. Riley & Co. Bryant Riley (L) and CEO, B. Riley & Co. Tom Kelleher. (Photo by Matt Winkelmeyer/Getty Images)

B.Riley Stock Soars Nearly 40% - What’s Behind The Move?

Company said it has filed its delayed quarterly reports and achieved NASDAQ compliance ahead of the deadline. 

<ul class="summary-bullets"><li>As part of the deal, Bitfarms will receive $9 million in cash upon closing, expected in Q1 2026.</li><li>The CEO said the deal brings forward an estimated 2 to 3 years of free cash flow from operations to be reinvested in our North American HPC/AI energy infrastructure in 2026.</li><li>Bitfarms plans to wind down its Bitcoin mining operations by 2027.</li></ul>Shares of bitcoin miner Bitfarms (<a href="https://stocktwits.com/symbol/BITF">BITF</a>) jumped more than 4% in premarket trading on Friday after it announced that it has entered into a definitive share purchase agreement to sell its 70 MW site in Paso Pe, Paraguay, to the Sympatheia Power Fund (SPF), a crypto infrastructure fund managed by Singapore-based Hawksburn Capital.The deal is valued at $30 million. Bitfarms will receive $9 million in cash upon closing, expected in Q1 2026, and up to $21 million over 10 months following closing, based on certain payment milestones, it stated.The sale of Paso Pe is the culmination of a series of transactions to completely exit LatAm and refocus the company, its management team, and capital on 100% North American power and infrastructure for HPC/AI.“This transaction brings forward an estimated two to three years of anticipated free cash flows from operations to be reinvested into our North American HPC/AI energy infrastructure in 2026,” Ben Gagnon, CEO at Bitfarms, said.<h2 class="st-heading-2">Pivot to HPC</h2>Bitfarms’ pivot into high-performance computing (HPC) and AI infrastructure comes at a time when crypto miners are increasingly struggling to make a profit as energy costs climb and Bitcoin has been showing weakness and thus are adapting to changing market conditions.It’s also not the only company to pivot towards artificial intelligence and high-performance computing. Several firms, including Core Scientific (CORZ), Iren (IREN), Hive Digital (HIVE), and Terawulf (WULF), have also announced similar strategic moves.Bitfarms plans to wind down its Bitcoin mining operations by 2027, and its transition will begin with its 18-megawatt site in Washington State. The company had said the facility would be converted into a liquid-cooled GPU facility designed for Nvidia’s next-generation GB300s.As part of its pivot, its CEO had <a href="https://stocktwits.com/news-articles/markets/equity/bitfarms-slumps-after-q3-miss-ceo-reaffirms-ai-pivot-with-nvidia/cLP92RaRE3m">stated</a> that the company is converting its Washington site and other assets to support AI workloads and cloud operations, backed by the company’s recent $588 million financing round. The core of the plan centers on NVIDIA’s next-generation Vera Rubin GPUs, expected to launch in Q4 2026.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around BITF trended in ‘extremely bearish’ territory amid ‘low’ message volumes.<img src="https://news.stocktwits-cdn.com/bitf_PNG_62282e1d56.webp" alt="bitf.PNG">For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the Bitfarms logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

From Bitcoin Mining To AI: What’s Driving BitFarms’ Stock Jump Today?

BitFarms agreed to sell its 70 MW site in Paraguay to a crypto infrastructure fund for $30 million as part of its plans to fully exit LatAm.

What’s Driving BitFarms’ Stock Jump Today

BitFarms agreed to sell its 70 MW site in Paraguay to a crypto infrastructure fund for $30 million as part of its plans to fully exit LatAm.


<ul class="summary-bullets"><li>The sale positions the company to reinvest capital in its core higher-growth segments, OSS said.&nbsp;</li><li>Bressner acquired Bressner for about $5.6 million in October 2018.&nbsp;</li><li>The company now expects revenue of $30 million to $32 million for the full year, marking year-over-year growth of 22% to 30%, in light of the transaction. &nbsp;</li></ul>Shares of One Stop Systems (OSS) jumped 6% after hours on Tuesday after the company announced the sale of all assets and operations of Bressner Technology GmbH and updated its full-year revenue outlook following the transaction.Hardware manufacturer OSS sold Bressner, which it acquired in October 2018, for $22.4 million to Hiper Euro GMBH on Tuesday. The sale positions the company to reinvest capital in its core higher-growth segments including deployable AI, real-time sensor processing, and rugged edge systems engineered for mission-critical defense and commercial environments, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/12/30/3211590/0/en/OSS-Announces-the-Sale-of-Bressner-Technology-GmbH-to-Hiper-Euro-GMBH.html">said.</a>Alongside the divestment, the company said it now expects revenue of $30 million to $32 million for the full year, marking year-over-year growth of 22% to 30%. OSS in November had said that it expects full-year consolidated revenue of $63 million to $65 million, including OSS segment revenue of $30 million to $32 million.<h2 class="st-heading-2">Pivot Into Higher-Growth Segments</h2>Bressner acquired Bressner for about $5.6 million and since then, Bressner has increased annual sales from approximately $18.3 million in 2019 to nearly $33 million on a trailing 12-month basis as of September 30, 2025, the company said.OSS President and CEO Mike Knowles termed the transaction an “important milestone” in the company’s evolution.“With a more focused, streamlined and simplified business, we expect to end 2025 with a significant cash position, no debt, strong year-over-year sales growth, and higher gross margin. We believe these actions establish a powerful foundation to deliver multi-year organic revenue growth of over 20%, higher gross margin, and pursue complementary opportunities that add new customers, technologies, and solutions across our core AI, ML, and edge markets,” Knowles said.<h2 class="st-heading-2">Updated Guidance</h2>Following the transaction, the company now expects positive full year adjusted core profit exclusive of the one-time pre-tax gain of nearly $7.4 million associated with the Bressner transaction.Bressner will be treated as a discontinued operation when the company reports results for the fourth quarter and full year 2025, OSS added.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around OSS jumped from ‘bearish’ to ‘bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘normal’ levels.A Stocktwits user applauded Tuesday's transaction as “asset-based financing done right.”<stembedurl>https://www.stocktwits.com/Momoware/message/640454421</stembedurl>Another highlighted that the company now has more cash for mergers and acquisitions.<stembedurl>https://www.stocktwits.com/TheBruss/message/640451591</stembedurl><a href="https://stocktwits.com/symbol/OSS">OSS stock</a> has more than doubled this year and over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-starts-cybercab-production-ahead-of-launch-in-2026/cL7IhipREyZ">Tesla Starts Cybercab Production Ahead Of Launch In 2026</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, the One Stop Systems (OSS) logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

One Stop Systems Stock Rises After Hours On Selling Bressner To Focus On Higher-Growth Segments

Hardware manufacturer OSS sold Bressner, which it acquired in October 2018, for $22.4 million to Hiper Euro GMBH on Tuesday.

<ul class="summary-bullets"><li>Cassava said that it intends to work “expeditiously” with the FDA and address the items flagged by the agency.</li><li>The company added that it no longer expects to initiate the trial in question in the first half of 2026.&nbsp;</li><li>Cassava discontinued Simufilam’s study in mild-to-moderate Alzheimer’s disease in March.</li></ul> Shares of Cassava Sciences, Inc.’s slid a deep 24% on Friday after the U.S. Food and Drug Administration placed a full clinical hold on the proposed proof-of-concept clinical trial for Simufilam in tuberous sclerosis complex -related epilepsy.The stock is now on track for its worst day in about 9 months.The company was informed by the FDA of the hold in a letter earlier this week, it said in a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001069530/000143774925038313/sava20251218_8k.htm">filing</a> with the Securities and Exchanges Commission. The company now has to provide the agency with additional information, including additional pre-clinical data, and modify the protocol design.Cassava said that it intends to work “expeditiously” with the FDA and address the items flagged by the agency. The company added that it no longer expects to initiate the trial in question in the first half of 2026.The company failed to provide a new timing for the study, and said it would depend on its ability to provide the requested information and on satisfactory completion of FDA’s review.<h2 class="st-heading-2">Cassava Hits Multiple Roadblocks With Simufilam</h2>Cassava <a href="https://stocktwits.com/news-articles/markets/equity/cassava-sciences-stock-drops-over-30-percent-after-drug-fails-study/ch7yzVjRbdz">discontinued</a> Simufilam’s study in mild-to-moderate Alzheimer’s disease in March after the drug did not fare better than placebo in reducing cognitive or functional decline in a late-stage study. The company discontinued its efforts to develop the drug for Alzheimer’s disease and phased out the program and then committed to evaluating the drug’s potential in TSC-related epilepsy.Tuberous Sclerosis Complex (TSC) is a rare genetic disorder causing non-cancerous tumors (hamartomas) to grow in many organs, primarily the brain, skin, kidneys, heart, lungs, and eyes. It can lead to symptoms including seizures, developmental delays, intellectual disabilities, and skin abnormalities.According to Austin-based Cassava, TSC affects nearly 50,000 people in the US and epilepsy is one of the most common neurological features of TSC, occurring in 84% of patients. Current therapies for the condition include antiepileptic drugs and mTOR inhibitors which are not fully effective, and are associated with serious adverse events, the company said in November.Cassava decided to study Simufilam in TSC-related epilepsy on the results of two sophisticated studies conducted in animals that support the drug’s potential, CEO Rick Barry said last month. &nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around SAVA fell from ‘bearish’ to ‘extremely bearish' territory over the past 24 hours, while message volume rose from ‘low’ to ‘high’ levels.A Stocktwits user highlighted a buying opportunity.<stembedurl>https://www.stocktwits.com/MrStockxy/message/639701864</stembedurl><a href="https://stocktwits.com/symbol/SAVA">SAVA stock</a> has dropped 8% this year and by 5% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/rocket-lab-stock-heads-for-its-best-day-in-over-8-months-rally-isn-t-only-about-trump/cLe0GDaREst">Rocket Lab Stock Heads For Its Best Day In Over 8 Months — And The Rally Isn’t Only About Trump</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Cassava Sciences Stock On Track For Worst Day In About 9 Months — What’s Driving Today’s Selloff?

FDA placed a clinical hold on the proposed proof-of-concept clinical trial for Simufilam in tuberous sclerosis complex -related epilepsy earlier this week.

Current Price	$77.00
Prev Close	$76.78
Open	$77.09
Dividend Yield	N/A
50-Day Moving Average	$73.53
Beta	N/A
Avg. Volume	659,474.74
PE Ratio	N/A

52-Week High	$78.11
52-Week Low	$56.73
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

DFAS
Dimensional ETF Trust - Dimensional U.S. Small Cap ETF

Feed

News

Sentiment

Fundamentals

Info

Latest DFAS News

DFASDimensional ETF Trust - Dimensional U.S. Small Cap ETF